Notification of Medical Policy Reviews September 2022

Medical Policy	Revision
Transplant: Stem Cell	CMS update; Additional coverage indications for Allogeneic Hematopoietic Stem Cell Transplantation added per new LCDL39270
Pharmacy Update	Expanding Medicare Part B Step Therapy and Prior Authorization requirements for medications under Part B effective October 3, 2022. Links: Blue Cross NC Medicare Advantage Expands Medicare Part B Step Therapy and Prior Authorization \| Blue Cross NC Blue Cross NC Medicare Part B Step Therapy Drug List (PDF)

Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.

Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語

© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.